tradingkey.logo

UK's MHRA Flags Guillain-Barré Syndrome Risk Post Abrysvo & Arexvy Vaccination In Adults 60 Years & Older

ReutersJul 7, 2025 1:51 PM

- UK's MHRA:

  • MHRA: THERE IS SMALL INCREASE IN RISK OF GUILLAIN-BARRÉ SYNDROME POST VACCINATION WITH ABRYSVO AND AREXVY IN ADULTS AGED 60 YEARS & OLDER -WEBSITE

  • UK'S MHRA: COMMISSION ON HUMAN MEDICINES ADVISE THAT BENEFITS OF VACCINATION AGAINST RSV OUTWEIGH SMALL RISK OF DEVELOPING GUILLAIN-BARRÉ SYNDROME

  • UK'S MHRA: CURRENTLY NO EVIDENCE OF INCREASED RISK OF GUILLAIN-BARRÉ SYNDROME IN PREGNANT WOMEN FOLLOWING VACCINATION WITH ABRYSVO

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI